Association of human papillomavirus type 31 variants with risk of cervical intraepithelial neoplasia grades 2-3

International Journal of Cancer

Volumn 131, Issue 10, 2012, Pages 2300-2307

  Xi, Long Fu ^a,b   Schiffman, Mark ^c   Koutsky, Laura A ^b   Hulbert, Ayaka ^a   Lee, Shu Kuang ^b   Defilippis, Victor ^d   Shen, Zhenping ^a   Kiviat, Nancy B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

cervical intraepithelial neoplasia; human papillomavirus; variants

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RISK; DISEASE ASSOCIATION; DNA DETERMINATION; DNA SEQUENCE; FEMALE; FOLLOW UP; GENETIC LINE; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMAN PAPILLOMAVIRUS 31; HUMANS; KAPLAN-MEIER ESTIMATE; NEOPLASM GRADING; PAPILLOMAVIRUS INFECTIONS; RISK; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84867041568     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27520     Document Type: Article

References (33)

1. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM,. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007; 121: 621-32.
2. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM,. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011; 128: 927-35.
3. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S,. Human papillomavirus and cervical cancer. Lancet 2007; 370: 890-907.
4. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H,. Classification of papillomaviruses. Virology 2004; 324: 17-27.
5. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM,. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010; 401: 70-9.
6. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB,. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 1997; 89: 796-802.
7. Zehbe I, Wilander E, Delius H, Tommasino M,. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 1998; 58: 829-33.
8. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL,. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000; 81: 2959-68.
9. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, et al. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 2001; 93: 315-8.
10. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de la Campa A,. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001; 93: 1325-30.
11. Schlecht NF, Burk RD, Palefsky JM, Minkoff H, Xue X, Massad LS, Bacon M, Levine AM, Anastos K, Gange SJ, Watts DH, Da Costa MM, et al. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J Gen Virol 2005; 86: 2709-20.
12. Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB,. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev 2007; 16: 4-10.
13. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 2010; 70: 3159-69.
14. Gagnon S, Hankins C, Tremblay C, Pourreaux K, Forest P, Rouah F, Coutlee F,. Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV-seronegative women at risk for HIV infection. J Med Virol 2005; 75: 213-21.
15. Cento V, Rahmatalla N, Ciccozzi M, Perno CF, Ciotti M,. Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology. J Med Virol 2011; 83: 1752-61.
16. Calleja-Macias IE, Kalantari M, Huh J, Ortiz-Lopez R, Rojas-Martinez A, Gonzalez-Guerrero JF, Williamson AL, Hagmar B, Wiley DJ, Villarreal L, Bernard HU, Barrera-Saldana HA,. Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 2004; 319: 315-23.
17. Calleja-Macias IE, Villa LL, Prado JC, Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Chu TY, Cubie HA, et al. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol 2005; 79: 13630-40.
18. Raiol T, Wyant PS, de Amorim RM, Cerqueira DM, Milanezi NG, Brigido Mde M, Sichero L, Martins CR,. Genetic variability and phylogeny of the high-risk HPV-31, -33, -35, -52, and -58 in central Brazil. J Med Virol 2009; 81: 685-92.
19. Cornut G, Gagnon S, Hankins C, Money D, Pourreaux K, Franco EL, Coutlee F,. Polymorphism of the capsid L1 gene of human papillomavirus types 31, 33, and 35. J Med Virol 2010; 82: 1168-78.
20. Safaeian M, van Doorslaer K, Schiffman M, Chen Z, Rodriguez AC, Herrero R, Hildesheim A, Burk RD,. Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties. Arch Virol 2010; 155: 367-70.
21. Chagas BS, Batista MV, Guimaraes V, Balbino VQ, Crovella S, Freitas AC,. New variants of E6 and E7 oncogenes of human papillomavirus type 31 identified in Northeastern Brazil. Gynecol Oncol 2011; 123: 284-8.
22. Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD,. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One 2011; 6: e20183.
23. Schiffman M, Adrianza ME,. ASCUS-LSIL triage study. design, methods and characteristics of trial participants. Acta Cytol 2000; 44: 726-42.
24. Hulbert A, DeFilippis V, Koutsky LA, Lee SA, Kiviat BN, Schiffman M, Xi LF,. Lineages of human papillomavirus type 31 variants: years before present and race-associated distribution. Virology, to be submitted.
25. Goldsborough MD, DiSilvestre D, Temple GF, Lorincz AT,. Nucleotide sequence of human papillomavirus type 31: a cervical neoplasia-associated virus. Virology 1989; 171: 306-11.
26. Drummond AJ, Rambaut A,. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 2007; 7: 214.
27. Hasegawa M, Kishino H, Yano T,. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 1985; 22: 160-74.
28. Lemeshow S, Hosmer DW, Jr., Estimating odds ratios with categorically scaled covariates in multiple logistic regression analysis. Am J Epidemiol 1984; 119: 147-51.
29. Cox DR,. Regression models and life tables. J Roy Statist Soc (Series B) 1972; 34: 187-220.
30. Stoppler MC, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J,. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 1996; 70: 6987-93.
31. Ordonez RM, Espinosa AM, Sanchez-Gonzalez DJ, Armendariz-Borunda J, Berumen J,. Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription. J Gen Virol 2004; 85: 1433-44.
32. De la Cruz-Hernandez E, Garcia-Carranca A, Mohar-Betancourt A, Duenas-Gonzalez A, Contreras-Paredes A, Perez-Cardenas E, Herrera-Goepfert R, Lizano-Soberon M,. Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences. J Gen Virol 2005; 86: 2459-68.
33. Sichero L, Franco EL, Villa LL,. Different P105 promoter activities among natural variants of human papillomavirus type 18. J Infect Dis 2005; 191: 739-42.